Long before a little boy in Puerto Rico received news that his leukemia had returned, a
St. Jude team of scientists and physicians had already been collaborating to create a therapy that might someday save his life.
When Marissa Boudreaux was a little girl, a
St. Jude clinical trial saved her life. Since that time, the hospital has taken dramatic steps toward identifying and treating patients with Ph-like ALL, the leukemia subtype she battled.